On November 2, 2022 Lantern Pharma Inc. (NASDAQ: LTRN), a clinical stage biopharmaceutical company using its proprietary RADR artificial intelligence ("A.I.") and machine learning ("M.L.") platform to transform the cost, pace, and timeline of oncology drug discovery and development, reported that Lantern management will be presenting at two upcoming investor conferences (Press release, Lantern Pharma, NOV 2, 2022, View Source [SID1234622821]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

BioFuture Conference in New York, NY on Tuesday, November 8th, 2022 at 2:00 p.m. ET. Panna Sharma, CEO & President, and David Margrave, CFO, will present.
Registration: View Source
Disruptive Growth Conference in New York, NY from December 5-6th, 2022. Panna Sharma, CEO & President, will present. Time of presentation to be announced.
Registration: View Source